Efficacy and safety of Shexiang Baoxin pill in patients with ischemia with non-obstructive coronary arteries (LESS): a phase 4, multicenter, randomized, double-blind, placebo-controlled clinical trial

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Acute and chronic coronary syndromes Clinical ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by